CD44 and neoplasm: However, as observed in ER+ disease, CD44+CD24-/low positive tumours were more often node-negative in ER- cases also, with 64% of CD44+CD24-/low positive tumours being node-negative compared to 51% of CD44+CD24-/low negative cases (P = 0.012).